» Articles » PMID: 9198203

Membrane-type Matrix Metalloproteinases (MT-MMPs) in Cell Invasion

Overview
Journal Thromb Haemost
Publisher Thieme
Date 1997 Jul 1
PMID 9198203
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Activated gelatinase A is reportedly associated with tumor spread. We identified a novel matrix metalloproteinase that localizes on the cell surface and mediate the activation of progelatinase A. Thus, this progelatinase A activator was named membrane-type matrix metalloproteinase (MT1-MMP). Following the first-discovery of MT1-MMP, two other MT-MMPs which can activate progelatinase A were identified (MT2- and MT3-MMP, respectively). Among these three MT-MMPs, MT1-MMP is most often overexpressed in malignant tumor tissues, including lung and stomach carcinomas that contain activated gelatinase A. This suggests that MT1-MMP is most closely associated with the activation of progelatinase A in these tumor tissues. The expression of MT1-MMP also induced binding of gelatinase A to the cell surface by functioning as a receptor. The cell surface localization of proteinases has advantages over pericellular proteolysis. MT1-MMP and its family may play a central role in the cell surface localization and activation of progelatinase A and via this mechanism, tumor cells use exogenous progelatinase A to mediate the proteolysis associated with invasion and metastasis.

Citing Articles

Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U-2 OS Cells through CD44 and Chemokine Signaling.

Fan L, Peng C, Zhu X, Liang Y, Xu T, Xu P Molecules. 2022; 27(12).

PMID: 35744840 PMC: 9231138. DOI: 10.3390/molecules27123714.


Alternagin-C binding to αβ integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells.

Moritz M, Eustaquio L, Micocci K, Nunes A, Santos P, de Castro Vieira T J Venom Anim Toxins Incl Trop Dis. 2018; 24:13.

PMID: 29713337 PMC: 5917863. DOI: 10.1186/s40409-018-0150-2.


Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus.

Endo T, Kiya T, Goto T, Henmi H, Manase K, Honnma H Reprod Med Biol. 2018; 5(4):235-243.

PMID: 29699252 PMC: 5904581. DOI: 10.1111/j.1447-0578.2006.00147.x.


MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.

Kaituu-Lino T, Palmer K, Tuohey L, Ye L, Tong S PLoS One. 2012; 7(6):e39864.

PMID: 22768148 PMC: 3387233. DOI: 10.1371/journal.pone.0039864.


New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Devy L, Dransfield D Biochem Res Int. 2010; 2011:191670.

PMID: 21152183 PMC: 2989751. DOI: 10.1155/2011/191670.